Clinical Trial Update: A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate Anaprazole for treating Reflux Esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• Anaprazole

Snippet

Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. | Conditions: Reflux Esophagitis (RE) | Phase 3 | Status: RECRUITING